BUZZ-Lexicon Pharmaceuticals rises on plan to lay off 60% of employees

Reuters11-23
BUZZ-Lexicon Pharmaceuticals rises on plan to lay off 60% of employees

** Lexicon Pharmaceuticals' LXRX.O shares rise 6.3% to 82 cents

** Co says it plans to cut about 60% of its workforce effective Dec. 31

** Co to shut down commercial operations and stop promotions for its approved heart failure treatment, Inpefa, but will continue production and supply for patients and existing prescribers

** Piper Sandler analysts say the Inpefa decision "removes capital constraints/overhang driving investor uncertainty"

** Says U.S. FDA noted deficiencies in LXRX's application seeking approval for the drug as an add-on treatment to insulin therapy for managing blood glucose levels in adults with type 1 diabetes and chronic kidney disease

** LXRX had 285 employees as of Mar 21, according to its latest annual report

** Including session's gains, stock has fallen 47.5% YTD

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment